Tresiba 100IU/ml Flextouch
Marketer
Novo Nordisk India Pvt Ltd
Salt Composition
Insulin Degludec (100IU/ml)
Overview Tresiba 100IU/ml Flextouch
Degludec insulin (Tresiba 100 IU/mL Flextouch) is a long-acting insulin formulation indicated for managing type 1 and type 2 diabetes in adults and pediatric patients. This medication delivers consistent insulin levels throughout the day, effectively regulating blood glucose and mitigating diabetes-related complications. Tresiba may be administered alone or in conjunction with rapid-acting insulin or other antidiabetic agents. Proper subcutaneous injection technique will be demonstrated by your healthcare provider. For optimal efficacy, consistent daily dosing at the same time is recommended. While flexibility exists regarding the exact administration time, a minimum 8-hour interval between injections must be maintained. Discontinuation may result in dangerously elevated blood sugar and severe health consequences. This medication is part of a comprehensive treatment plan encompassing dietary modifications, physical activity, and weight management as directed by your physician. Hypoglycemia (low blood sugar) is a common adverse effect. To minimize this risk, accurate dosing, regular meals, and diligent blood glucose monitoring are crucial. Excessive alcohol consumption can also exacerbate hypoglycemia. Additional side effects include injection site reactions (redness, swelling, lipohypertrophy) and potential weight gain. Tresiba should not be used during episodes of hypoglycemia. Prior to initiating treatment, individuals with pre-existing kidney, liver, or heart conditions should inform their doctor. Pregnant or lactating women must consult their physician before commencing treatment.
Primary Ingredients of Tresiba 100IU/ml Flextouch
No text provided. Please provide the text you would like me to rewrite.
Uses of Tresiba 100IU/ml Flextouch
High blood sugar condition
Major Benefits of Tresiba 100IU/ml Flextouch:
Your healthcare provider will instruct you on the proper administration of this medication.
Common Side effects of Tresiba 100IU/ml Flextouch:
- Auto-antibody formation
- Headache
- Injection site reactions (pain, swelling, redness)
- Severe hypoglycemia
- Nasopharyngitis (inflammation of the throat and nasal passages)
- Upper respiratory tract infection
How to use Tresiba 100IU/ml Flextouch:
Your healthcare provider will instruct you on the proper administration of this medication.
How Tresiba 100IU/ml Flextouch works:
Degludec insulin (Tresiba 100 IU/mL Flextouch pen) offers prolonged glycemic control throughout the day, mimicking the function of endogenous insulin. This action involves glucose uptake enhancement in muscle and adipose tissue, alongside hepatic glucose production inhibition.
SAFETY ADVICE
AlcoholUNSAFE
Combining Tresiba 100 IU/ml Flextouch and alcohol is unsafe.
PregnancySAFE IF PRESCRIBED
The use of Tresiba 100 IU/ml Flextouch during pregnancy is typically deemed safe. Preclinical trials in animals revealed minimal or absent negative consequences for fetal development; nevertheless, data from human trials are scarce.
Breast feedingSAFE IF PRESCRIBED
Using Tresiba 100 IU/ml Flextouch while breastfeeding appears to be unlikely to cause harm. Available data from human studies indicate minimal risk to the infant.
DrivingCAUTION
Driving may be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.
KidneyCAUTION
For individuals with impaired kidney function, the use of Tresiba 100 IU/ml Flextouch requires careful consideration. Dosage modifications of Tresiba 100 IU/ml Flextouch may be necessary. Physician consultation is recommended. Close and consistent monitoring of blood glucose is crucial.
LiverCAUTION
For individuals with hepatic impairment, administering Tresiba 100 IU/ml Flextouch requires careful consideration. Dosage modification of Tresiba 100 IU/ml Flextouch might be necessary. Physician consultation is recommended. Close, consistent monitoring of blood glucose is advisable.
What if you forget to take Tresiba 100IU/ml Flextouch :
Remember to administer your Tresiba 100 IU/ml Flextouch injection as soon as possible if you miss a dose. However, avoid taking another dose within an 8-hour timeframe of the previous one.
Facts to Know About Tresiba 100IU/ml Flextouch
Label | Value |
---|---|
Chemical Type | Modified insulin |
Developing Habits | No. |
Type of Treatment | Diabetes Management |